BioNexus Gene Lab Corp. (BGLC)

BioNexus Gene Lab Revenue

BioNexus Gene Lab had revenue of $76.16K in the quarter ending June 30, 2026, a decrease of -96.63%. This brings the company's total for the last twelve months to $3.13M, down -67.27% year-over-year. In the year 2025, BioNexus Gene Lab had annual revenue of $7.42M, down -21.93%. That makes BioNexus Gene Lab the 41,371st largest company in the world by revenue and 5,570th in the United States.

• Revenue (ttm): $3.13M
• Revenue Growth: -67.27%
• P/S Ratio: 0.78
• Revenue / Employee: $164,557
• Employees: 19
• Market Cap: 2.43M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Trading of Industrial Chemicals 7.41M 99.7%
• Provision for Genomic Screening Services 19.09K 0.3%

By Geography

Chart

• Malaysia 5.83M 78.5%
• Maldives 680.99K 9.2%
• Sri Lanka 452.64K 6.1%
• Singapore 240.76K 3.2%
• Indonesia 114.87K 1.5%
• Bangladesh 106.25K 1.4%

Fiscal year ended Dec 31, 2025 See the full BioNexus Gene Lab breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	7.42M	-2.09M	-21.93%
Dec 31, 2024	9.51M	-260.16K	-2.66%
Dec 31, 2023	9.77M	-1.16M	-10.60%
Dec 31, 2022	10.93M	-2.43M	-18.21%
Dec 31, 2021	13.36M	1.97M	17.31%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error